As of 2025-10-30, the Relative Valuation of Cullinan Oncology Inc (CGEM) is (75.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.69 USD, the upside of Cullinan Oncology Inc based on Relative Valuation is -1082.0%.
The range of the Relative Valuation is (65.32) - (77.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 22.1x | 19.6x |
| Forward P/E multiples | 18.7x - 28.4x | 23.6x |
| Fair Price | (65.32) - (77.22) | (75.52) |
| Upside | -949.4% - -1104.1% | -1082.0% |
| Date | P/E |
| 2025-10-30 | -2.23 |
| 2025-10-29 | -2.20 |
| 2025-10-28 | -2.43 |
| 2025-10-27 | -2.30 |
| 2025-10-24 | -2.22 |
| 2025-10-23 | -2.21 |
| 2025-10-22 | -2.32 |
| 2025-10-21 | -2.42 |
| 2025-10-20 | -2.45 |
| 2025-10-17 | -2.24 |
| 2025-10-16 | -2.50 |
| 2025-10-15 | -2.47 |
| 2025-10-14 | -2.21 |
| 2025-10-13 | -2.24 |
| 2025-10-10 | -2.11 |
| 2025-10-09 | -2.01 |
| 2025-10-08 | -1.84 |
| 2025-10-07 | -1.68 |
| 2025-10-06 | -1.67 |
| 2025-10-03 | -1.69 |
| 2025-10-02 | -1.64 |
| 2025-10-01 | -1.71 |
| 2025-09-30 | -1.69 |
| 2025-09-29 | -1.71 |
| 2025-09-26 | -1.70 |
| 2025-09-25 | -1.71 |
| 2025-09-24 | -1.72 |
| 2025-09-23 | -1.74 |
| 2025-09-22 | -1.79 |
| 2025-09-19 | -1.77 |
| 2025-09-18 | -1.81 |
| 2025-09-17 | -1.69 |
| 2025-09-16 | -1.80 |
| 2025-09-15 | -1.81 |
| 2025-09-12 | -1.87 |
| 2025-09-11 | -1.89 |
| 2025-09-10 | -1.85 |
| 2025-09-09 | -1.95 |
| 2025-09-08 | -1.95 |
| 2025-09-05 | -2.00 |
| 2025-09-04 | -1.97 |
| 2025-09-03 | -2.21 |
| 2025-09-02 | -2.14 |
| 2025-08-29 | -2.15 |
| 2025-08-28 | -2.17 |
| 2025-08-27 | -2.27 |
| 2025-08-26 | -2.18 |
| 2025-08-25 | -2.18 |
| 2025-08-22 | -2.34 |
| 2025-08-21 | -2.19 |